Burbank, California Clinical Trials

A listing of Burbank, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 54 clinical trials
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

Investigational Site Number 8400059
 (8.4 away)
  • 0 views
  • 19 Feb, 2024
  • +31 other locations
An Open-label Ascending Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 2-17 years with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) in order to identify the dose and regimen for adequate treatment of this population Secondary Objective: To describe the pharmacodynamic (PD) profile, the efficacy and the long-term safety of …

anti-rheumatic drugs
disease modifying antirheumatic drugs
rheumatoid factor
antirheumatic
arthritis
Investigational Site Number 8400416
 (4.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +33 other locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

hemophilia
fitusiran
bethesda assay
haemophilia a
antihemophilic factor
Investigational Site Number 8400002
 (4.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
None

Los Angeles Cancer Network
 (9.0 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

paclitaxel
lung carcinoma
squamous cell carcinoma of lung
antiretroviral therapy
carcinoma
Providence Saint Joseph Medical Center/Disney Family Cancer Center
 (2.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
Dupilumab Asthma Sleep Study

Primary Objective: To assess the effect of dupilumab on sleep Secondary Objectives: To evaluate the effect of dupilumab on additional patient reported sleep outcomes To evaluate the effect of dupilumab on objective sleep assessment To evaluate the effect of dupilumab on asthma symptoms To evaluate the effect of dupilumab on …

fractional exhaled nitric oxide
corticosteroids
dupilumab
leukotriene receptor antagonist
pulmonary function test
Investigational Site Number 8400009
 (8.2 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +10 other locations
None

Los Angeles Cancer Network
 (9.0 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

Los Angeles Cancer Network
 (9.0 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

Carbon Health - North Hollywood - NoHo West- Site Number : 8400076
 (4.6 away) Contact site
  • 0 views
  • 29 Nov, 2025
  • +30 other locations
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

tricuspid valve replacement
medical therapy
Cedars-Sinai Medical Center
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations